STRUCTURE-ACTIVITY-RELATIONSHIPS IN A SERIES OF 5-[(2,5-DIHYDROXYBENZYL)AMINO]SALICYLATE INHIBITORS OF EGF-RECEPTOR-ASSOCIATED TYROSINE KINASE - IMPORTANCE OF ADDITIONAL HYDROPHOBIC AROMATIC INTERACTIONS

被引:32
作者
CHEN, HX
BOIZIAU, J
PARKER, F
MAILLIET, P
COMMERCON, A
TOCQUE, B
LEPECQ, JB
ROQUES, BP
GARBAY, C
机构
[1] FAC PHARM PARIS,DEPT PHARMACOCHIM MOLEC & STRUCT,CNRS,URA D1500,INSERM,U266,F-75270 PARIS 06,FRANCE
[2] RHONE POULENC RORER,F-94403 VITRY,FRANCE
关键词
D O I
10.1021/jm00032a020
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Potent inhibitors of EGF-dependent protein tyrosine kinase (PTK) activity were synthesized in a series of 5-[(2,5-dihydroxybenzyl)amino]salicylates. Several of these compounds inhibited EGF-dependent DNA synthesis in ER 22 cells with IC50 < 1 muM. In this series of PTK inhibitors, the role of the salicylate moiety as a potential divalent ion chelator was tested and found to be nonessential in all cases. The length and ramification of the substituting carboxyl group were investigated to improve cellular bioavailability, and this analysis provided compounds with increased inhibitory effect on EGF-induced DNA synthesis. Salicylates esterified with long hydrophobic chains were shown to be noncompetitive inhibitors of ATP, in contrast to the free acid and methyl salicylate. Moreover, all the tested inhibitors were shown to be noncompetitive inhibitors of the peptide substrate. Structure-activity relationships allowed us to suspect a hydrophobic pocket in the tyrosine kinase domain, preferentially interacting with aromatic rings. Finally, the selectivity of the best inhibitors was tested against other kinases, and they were found to be selective for tyrosine kinase. They were also shown to be good inhibitors of EGF-receptor autophosphorylation.
引用
收藏
页码:845 / 859
页数:15
相关论文
共 54 条
[1]   SELECTIVE-INHIBITION OF TYROSINE PROTEIN-KINASE BY A SYNTHETIC MULTISUBSTRATE ANALOG [J].
BAGINSKI, I ;
COMMERCON, A ;
TOCQUE, B ;
COLSON, G ;
ZERIAL, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (03) :1324-1330
[2]  
BARKER AJ, EP520722
[3]   CELLULAR ONCOGENES AND RETROVIRUSES [J].
BISHOP, JM .
ANNUAL REVIEW OF BIOCHEMISTRY, 1983, 52 :301-354
[4]  
BURKE T R JR, 1992, Drugs of the Future, V17, P119
[5]   ONCOGENES AND SIGNAL TRANSDUCTION [J].
CANTLEY, LC ;
AUGER, KR ;
CARPENTER, C ;
DUCKWORTH, B ;
GRAZIANI, A ;
KAPELLER, R ;
SOLTOFF, S .
CELL, 1991, 64 (02) :281-302
[6]   ANTIBODIES TO THE EPIDERMAL GROWTH-FACTOR RECEPTOR BLOCK THE BIOLOGICAL-ACTIVITIES OF SARCOMA GROWTH-FACTOR [J].
CARPENTER, G ;
STOSCHECK, CM ;
PRESTON, YA ;
DELARCO, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (18) :5627-5630
[7]  
CARPENTER G, 1979, J BIOL CHEM, V254, P4884
[8]   PROTEIN-TYROSINE KINASE INHIBITION - MECHANISM-BASED DISCOVERY OF ANTITUMOR AGENTS [J].
CHANG, CJ ;
GEAHLEN, RL .
JOURNAL OF NATURAL PRODUCTS, 1992, 55 (11) :1529-1560
[9]   SYNTHESIS AND STRUCTURE-ACTIVITY STUDIES OF A SERIES OF [(HYDROXYBENZYL)AMINO]SALICYLATES AS INHIBITORS OF EGF RECEPTOR-ASSOCIATED TYROSINE KINASE-ACTIVITY [J].
CHEN, HX ;
BOIZIAU, J ;
PARKER, F ;
MAROUN, R ;
TOCQUE, B ;
ROQUES, BP ;
GARBAYJAUREGUIBERRY, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (25) :4094-4098
[10]   INCREASED TYROSINE PHOSPHORYLATION IN RAS TRANSFORMED FIBROBLASTS OCCURS PRIOR TO MANIFESTATION OF THE TRANSFORMED PHENOTYPE [J].
CUADRADO, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 170 (02) :526-532